AK Global Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.4M Hold
39,645
– – 8.12% 3
2026
Q2
$10M Hold
39,645
– – 8.45% 3
2026
Q1
$8.62M Hold
39,645
– – 8.11% 3
2025
Q4
$9.06M Buy
+39,645
New +$9.03M 7.92% 3

Other funds holding ABBV

AK Global Asset Management's ABBV Position: Q3 2026 in Review

AK Global Asset Management held its AbbVie (ABBV) position steady in Q3 2026 at 39,645 shares worth $10.4M. The position accounts for 8.12% of the portfolio, ranked #3.

AK Global Asset Management first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,272 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • AK Global Asset Management held 39,645 shares of AbbVie worth $10.4M as of Q3 2026.
  • AK Global Asset Management left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 8.12% of AK Global Asset Management's portfolio in Q3 2026, its #3 holding.
  • AK Global Asset Management first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 4,272 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on AK Global Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.